Breaking News Instant updates and real-time market news.

ABCO

The Advisory Board

$52.05

-1.35 (-2.53%)

16:25
08/08/17
08/08
16:25
08/08/17
16:25

The Advisory Board sees FY17 revenue $780.0M-$840.0M, consensus $809.07M

Sees FY17 adjusted EPS $1.80-$2.10, consensus $1.97.

ABCO The Advisory Board
$52.05

-1.35 (-2.53%)

03/10/17
RHCO
03/10/17
DOWNGRADE
Target $45
RHCO
Hold
The Advisory Board downgraded to Hold from Buy at SunTrust
SunTrust analyst Sandy Draper downgraded The Advisory Board to Hold due to lack of upside to his $45 price target. The analyst is not urse if the company will be sold, but thinks it could fetch $50 in a deal or down to $40 if a sale does not occur.
03/27/17
BARD
03/27/17
UPGRADE
BARD
Outperform
The Advisory Board upgraded to Outperform from Neutral at Baird
03/27/17
03/27/17
UPGRADE

Outperform
The Advisory Board upgraded to Outperform, takeout more likely, says Baird
As previously reported, Baird upgraded The Advisory Board to Outperform from Neutral and raised its price target to $53 from $50. Analyst Matthew Gillmor believes the likelihood of the company being acquired has increased considerably in recent days, given reported interest from multiple strategic buyers. Further, potential downside risk remains relatively limited considering the strong rally within the Health IT group combined with Elliot's involvement threat of activist demands, the analyst wrote. Gillmor views a $55 takeout price as reasonable, with upside into the low $60s depending on the buyer's view of strategic value.
03/31/17
WELS
03/31/17
NO CHANGE
WELS
Outperform
Wells 'strongly' recommends Evolent, says Advisory Board deal unlikely
After hosting investor meetings with management, Wells Fargo analyst Jamie Stockton says he continues to "strongly" recommend shares of Evolent Health. In a research note titled "Stay Thirsty," the analyst argues that few companies in Digital Health could be "World's Most Interesting" and that Evolent "might just take the cake." While the company did not explicitly comment on the Advisory Board (ABCO) M&A speculation floated by Reuters, it stated that it has no intention of doing anything that would materially change the growth profile, Stockton tells investors. He interprets this as a "no" regarding the merger happening. The analyst adds that Evolent is talking to several dozen organizations around the next generation accountable care organization cohort and has two roughly $100M managed Medicaid opportunities. Stockton keeps an Outperform rating on Evolent with a $24-$28 price target range.

TODAY'S FREE FLY STORIES

PCG

PG&E

$39.90

(0.00%)

09:39
06/20/18
06/20
09:39
06/20/18
09:39
Recommendations
PG&E analyst commentary  »

Morgan Stanley sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

09:37
06/20/18
06/20
09:37
06/20/18
09:37
Conference/Events
House Financial Services Committee to hold a hearing »

The Terrorism &…

MKSI

MKS Instruments

$103.90

(0.00%)

, SSNLF

Samsung

$0.00

(0.00%)

09:36
06/20/18
06/20
09:36
06/20/18
09:36
Recommendations
MKS Instruments, Samsung analyst commentary  »

MKS Instruments offers…

MKSI

MKS Instruments

$103.90

(0.00%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

09:35
06/20/18
06/20
09:35
06/20/18
09:35
General news
U.S. existing home sales preview: »

U.S. existing home sales…

GE

General Electric

$12.96

(0.00%)

09:34
06/20/18
06/20
09:34
06/20/18
09:34
Recommendations
General Electric analyst commentary  »

GE's 'here to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:34
06/20/18
06/20
09:34
06/20/18
09:34
Hot Stocks
Johnson says 'not immune' to geopolitical events, focused on long-term in China »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

AMZN

Amazon.com

$1,735.74

(0.00%)

, JPM

JPMorgan

$107.58

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Hot Stocks
Amazon-Berkshire-JPMorgan healthcare joint venture names Atul Gawande CEO »

Amazon (AMZN), Berkshire…

AMZN

Amazon.com

$1,735.74

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

ITRI

Itron

$58.50

(0.00%)

, SPKE

Spark Energy

$10.30

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Recommendations
Itron, Spark Energy analyst commentary  »

Itron added to Best Ideas…

ITRI

Itron

$58.50

(0.00%)

SPKE

Spark Energy

$10.30

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$44.72

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson trends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
06/20/18
06/20
09:30
06/20/18
09:30
General news
The U.S. current account gap widened »

The U.S. current account…

VHC

VirnetX

$3.45

(0.00%)

09:29
06/20/18
06/20
09:29
06/20/18
09:29
Hot Stocks
VirnetX enters reseller agreement with Above PAR Advisors »

VirnetX has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$33.21

(0.00%)

, SRPT

Sarepta

$143.92

(0.00%)

09:27
06/20/18
06/20
09:27
06/20/18
09:27
Recommendations
PTC Therapeutics, Sarepta analyst commentary  »

PTC Therapeutics weakness…

PTCT

PTC Therapeutics

$33.21

(0.00%)

SRPT

Sarepta

$143.92

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

AMZN

Amazon.com

$1,735.74

(0.00%)

, BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Breaking Hot Stocks news story on Amazon.com, Berkshire Hathaway, Berkshire Hathaway, JPMorgan »

Amazon, Berkshire,…

AMZN

Amazon.com

$1,735.74

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

TLGT

Teligent

$3.70

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Teligent announces FDA approval of Fluocinonide Gel, 0.05% »

Teligent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$207.24

(0.00%)

, TST

TheStreet

$1.78

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
S&P Global confirms purchase of RateWatch business from TheStreet »

S&P Global (SPGI)…

SPGI

S&P Global

$207.24

(0.00%)

TST

TheStreet

$1.78

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
06/20/18
06/20
09:25
06/20/18
09:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD topped…

AZZ

AZZ Inc.

$44.93

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Energy Subcommittee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTEX

Mannatech

$20.40

(0.00%)

09:24
06/20/18
06/20
09:24
06/20/18
09:24
Hot Stocks
Mannatech announces final results of modified Dutch auction tender offer »

Mannatech announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$127.56

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Hot Stocks
Starbucks CEO says 'some canibalization,' new entrants hurt China SSS in Q3 »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EMCI

EMC Insurance

$27.28

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Upgrade
EMC Insurance rating change  »

EMC Insurance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIN

Kindred Biosciences

$10.00

(0.00%)

09:20
06/20/18
06/20
09:20
06/20/18
09:20
Syndicate
Kindred Biosciences 4.632M share Spot Secondary priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

RUT

Russell 2000 Index

$0.00

(0.00%)

, IWM

iShares Trust Russell 2000 Index Fund

$168.64

(0.00%)

09:20
06/20/18
06/20
09:20
06/20/18
09:20
Technical Analysis
Technical Take: iShares Trust Russell 2000 Index Fund hits new life high »

In pre-market trading the…

RUT

Russell 2000 Index

$0.00

(0.00%)

IWM

iShares Trust Russell 2000 Index Fund

$168.64

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:19
06/20/18
06/20
09:19
06/20/18
09:19
Hot Stocks
Starbucks CEO sees transitioning to 'growth at scale' phase »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.